Yvonne Briggs
Investor Relations, LHA
Replay available
ENDRA Life Sciences Inc. (NASDAQ: NDRA) Q1 2023 earnings conference call, held 2023-05-15. Replay captured from the company's public earnings webcast.

Investor Relations, LHA
Chairman and Chief Executive Officer
Chief Technology Officer
Senior Director of Finance
Analyst, Ascendant Capital
Watch the replay and follow the connected company analysis, news, and investor updates for Endra Life Sciences Inc..
WEBVTT 00:00:00.009 -- 00:00:03.150 Good day, and welcome to the Andrea Life Sciences, Inc. 00:00:03.150 -- 00:00:04.870 First Quarter 2023 00:00:04.870 -- 00:00:10.712 Financial Results Conference Call. All participants will be in listen-only mode. 00:00:10.712 -- 00:00:14.253 Should you need assistance, please signal a conference specialist by pressing the star 00:00:14.253 -- 00:00:16.654 key followed by zero. 00:00:16.654 -- 00:00:21.376 After today's presentation, there will be an opportunity to ask questions. 00:00:21.376 -- 00:00:26.297 To ask a question, you may press star then one on your telephone keypad. 00:00:26.297 -- 00:00:30.165 To withdraw your question, please press star then two. 00:00:30.165 -- 00:00:34.987 Please note this event is being recorded. I would now like to turn the conference over 00:00:34.987 -- 00:00:38.888 to Yvonne Briggs. Please go ahead. 00:00:38.888 -- 00:00:42.310 Thank you, operator. This is Yvonne Briggs with LHA. 00:00:42.310 -- 00:00:45.651 Good afternoon and welcome to NDRA's first quarter 2023 00:00:45.651 -- 00:00:48.792 business update and financial results conference call. 00:00:48.792 -- 00:00:54.014 Earlier today, NDRA issued a press release on this topic, which is available in the investor 00:00:54.014 -- 00:00:59.131 section of NDRA's website. Before we begin, please note that today's discussion will 00:00:59.131 -- 00:01:03.694 include forward-looking statements. All statements by management, other than statements 00:01:03.694 -- 00:01:08.116 of historical facts, including statements regarding the company's strategies, financial 00:01:08.116 -- 00:01:13.239 condition, operations, costs, plans and objectives, as well as 00:01:13.239 -- 00:01:18.463 anticipated results of development and commercialization efforts, th...